Latest News and Press Releases

Las Vegas, NV, Aug. 15, 2018 (GLOBE NEWSWIRE) -- For the three months that ended June 30, 2018, GB Sciences, Inc. (OTCQB: GBLX) reported revenue of $1,315,284 and gross profit of  $734,719.  This...

Las Vegas, NV, July 31, 2018 (GLOBE NEWSWIRE) -- GB Sciences, Inc (OTCQB:GBLX) has contracted Adherence Compliance, a leading cannabis compliance software and services firm, for its Chief Compliance...

Las Vegas, June 27, 2018 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB: GBLX) has filed a new provisional patent application on the use of cannabis-based therapies for the manipulation of...

Las Vegas, NV, May 23, 2018 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB: GBLX) For large scale adoption of Cannabis in medical formulations the quality, consistency and trust in the raw...

PHOENIX, April 19, 2018 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB:GBLX) (“the “Company”), today announced CEO, John Poss, returned to Uptick Newswire’s “Stock Day” podcast with Everett Jolly for...

PHOENIX, Feb. 06, 2018 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB:GBLX) (the “company”), discusses 2017 achievements and 2018 operations expectations, on Stock Day Podcast with Everett Jolly. “It...

Phoenix, AZ, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast and after airing back in January 2016 CEO and host Everett Jolly has...

Las Vegas, NV, Nov. 13, 2017 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB: GBLX) announces that it has met the October gross revenue projection of $500K from the sale of premium flower. Gross sales...

Las Vegas, NV, Nov. 01, 2017 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB: GBLX) inducts a Scientific Advisory Board to provide oversight for product development within GB Sciences’ intellectual...

Las Vegas, NV, October 30, 2017/GLOBE Newswire, Oct. 30, 2017 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB: GBLX) and Cura Cannabis Solutions (Cura) have executed a production agreement to produce...